Skip to content
healthcare.dev

Potassium Chloride

NDC 71610-343, potassium chloride, tablet, extended release, from Aphena Pharma Solutions - Tennessee, LLC.

Product NDC
71610-343
Status
Listed
Labeler
Aphena Pharma Solutions - Tennessee, LLC
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA074726
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/71610-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • POTASSIUM CHLORIDE1500 mg/1

Pharmacologic classes

Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Potassium Compounds [CS]; Potassium Salt [EPC]

Package NDCNDC-11Package
71610-343-157161003431515 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-15)
71610-343-307161003433030 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-30)
71610-343-457161003434545 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-45)
71610-343-537161003435360 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-53)
71610-343-607161003436090 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-60)
71610-343-7071610034370120 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-70)
71610-343-7371610034373135 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-73)
71610-343-8071610034380180 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-80)
71610-343-9071610034390240 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-90)
71610-343-9271610034392270 TABLET, EXTENDED RELEASE in 1 BOTTLE (71610-343-92)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/d2e84d34-e042-477f-9944-3fcb95301217

Use it

Look up 71610-343 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/71610-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 71610-343. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.